All Posts

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Last week we saw a number of buyouts and saw the JP Morgan conference. As we continue to move through this quarter we see a number of...

Last week we saw a number of buyouts and had the JP Morgan conference. As we move through this quarter we see a number of PDUFA events...

See Table 1 for all Stock Market Holidays where the NASDAQ stock market is closed. Table 1. Stock market holidays in 2023 If you are...

Last updated 1/12/2023 Summary: MDGL read out Phase 3 topline data on December 19, leading to a stock move of over +250%! Many other NASH...

Last updated 3/1/23

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

We ended the previous week with the FDA approval for Lecanemab treating Alzheimer's. We'll track and share the future events as they...

We ended the previous week with the FDA approval for Lecanemab treating Alzheimer's. We'll track and share the future events as they...

Summary: The biotech sector saw many exciting events and readouts in 2022 While smid-cap biopharmas were down more than 20% during 2022,...